[作为药理目标的包裹病毒入口:病毒膜融合机械及其抑制剂]
S V Cheresiz1,2, E A Ulyanova1, A G Pokrovsky1
1Zelman's Institute of Medicine and Psychology, Novosibirsk State University, Novosibirsk, 630090 Russia.
Molekuliarnaia biologiia
|October 15, 2025
概括
病毒融合葡萄糖蛋白调解包裹病毒的进入. 通过向病毒葡萄糖蛋白结构和功能,抑制这一过程为抗病毒疗法提供了优势,从而导致新的进入抑制剂.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 包裹病毒进入宿主细胞是感染的关键早期阶段.
- 病毒融合葡萄糖蛋白调解这种进入过程,使它们成为抗病毒策略的关键目标.
- 尽管结构多样化,病毒融合葡萄糖蛋白具有功能相似性,包括不同的受体结合和膜融合领域.
研究的目的:
- 描述所有三类病毒融合糖蛋白的膜融合机制.
- 为了识别这些糖蛋白内的特定域和结构,可以被进入抑制剂准.
- 提供现有进入抑制剂的例子,并讨论广泛作用抑制剂的未来前景.
主要方法:
- 审查和描述病毒融合糖蛋白的结构和功能特征.
- 通过这些糖蛋白质调解的膜融合过程的分析.
- 进入抑制剂的不同类别的分类和例子.
主要成果:
- 病毒融合葡萄糖蛋白,尽管结构不同,但共享保护的功能域,对于膜融合至关重要.
- 特定的结构元素,包括融合/循环和膜近端外部区域 (MPER),对于融合至关重要.
- 已经开发出了针对糖蛋白功能的不同阶段的各种进入抑制剂,例如受体结合和融合.
结论:
- 向病毒融合糖蛋白为开发有效的抗病毒疗法提供了一个有前途的战略.
- 了解病毒融合机制的详细机制和结构是设计新型进入抑制剂的关键.
- 对这些目标的进一步研究有可能开发广泛作用的抗病毒药物.
更多相关视频
06:03Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
Published on: July 15, 2019
8.3K
07:22A High-throughput Cre-Lox Activated Viral Membrane Fusion Assay to Identify Inhibitors of HIV-1 Viral Membrane Fusion
Published on: August 14, 2018
6.9K
相关概念视频
Introduction to Virus
1.2K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
1.2K
SNAREs and Membrane Fusion
12.3K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
12.3K
Viral Structure
73.8K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
73.8K
What are Viruses?
127.6K
Overview
127.6K
Fusion of Secretory Vesicles with the Plasma Membrane
16.5K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
16.5K
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
